SKP 450

Drug Profile

SKP 450

Alternative Names: KR 30450

Latest Information Update: 26 Mar 2008

Price : $50

At a glance

  • Originator Korea Research Institute of Chemical Technology
  • Developer SK Pharma
  • Class Benzopyrans; Dioxolanes; Pyrrolidinones; Small molecules
  • Mechanism of Action Potassium channel agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Discontinued Hypertension; Myocardial ischaemia

Most Recent Events

  • 05 Nov 2002 No development reported - Phase-I for Hypertension in South Korea (unspecified route)
  • 05 Nov 2002 No development reported - Phase-I for Myocardial ischaemia in South Korea (unspecified route)
  • 09 Oct 2000 A study has been added to the Hypertension pharmacodynamics section
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top